← Leaderboards
Joseph M Ready
Yale University
$10,879,736
Attributed
$21,008,144
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,008,144 · 8
By mechanism
R01$8,278,862 · 4
RM1$6,903,660 · 1
UM1$4,553,009 · 1
U54$1,211,426 · 1
F32$61,187 · 1
Top collaborators
- Sanford D Markowitz9 shared
- Margaret A. Phillips8 shared
- Andrew A Pieper7 shared
- Derek James Taylor4 shared
- Stanton L Gerson3 shared
- David Glenn Mcfadden2 shared
Most similar at Yale University
Same institution · by research overlap
- John Greally$14,293,659
- Elsa Chui-Ying Yan$1,994,809
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureProgramsCellsLeadComplexPharmaceutical PreparationsIn VivoSmall MoleculeDrug DiscoveryPharmaceutical ChemistryBiochemicalAnalogBiologyScaffoldBiologicalLiverMouse ModelProtocols DocumentationChemistryPatternGeneticDesignProteinsDose
Grant awards (34)
Targeting transcriptional addiction in fusion-driven sarcoma$2,349,362
UM1 · FY2025 · CA
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration$1,354,462
RM1 · FY2025 · GM · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$717,556
R01 · FY2025 · AI
Targeting transcriptional addiction in fusion-driven sarcoma$2,203,647
UM1 · FY2024 · CA
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration$1,354,462
RM1 · FY2024 · GM · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$737,236
R01 · FY2024 · AI
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration$94,538
RM1 · FY2024 · GM · contact PI
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration$39,393
RM1 · FY2024 · GM · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$18,655
R01 · FY2024 · AI
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration$1,354,462
RM1 · FY2023 · GM · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$737,236
R01 · FY2023 · AI
Optimization of novel phenotypic screening hits for treatment of Malaria$81,180
R01 · FY2023 · AI
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration$1,345,312
RM1 · FY2022 · GM · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$737,236
R01 · FY2022 · AI
Optimization of novel phenotypic screening hits for treatment of Malaria$62,525
R01 · FY2022 · AI
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration$1,361,031
RM1 · FY2021 · GM · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$752,336
R01 · FY2021 · AI
Medicinal Chemistry$1,211,426
U54 · FY2019 · CA · contact PI
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation$490,048
R01 · FY2019 · CA · contact PI
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation$505,206
R01 · FY2018 · CA · contact PI
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation$401,377
R01 · FY2018 · CA · contact PI
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation$520,706
R01 · FY2017 · CA · contact PI
Synthesis and Evaluation of Biologically Active Natural Products$294,701
R01 · FY2016 · GM · contact PI
Synthesis and Evaluation of Biologically Active Natural Products$294,701
R01 · FY2015 · GM · contact PI
Synthesis and Evaluation of Biologically Active Natural Products$294,701
R01 · FY2014 · GM · contact PI
Synthesis and Evaluation of Biologically Active Natural Products$294,701
R01 · FY2013 · GM · contact PI
Catalytic Synthesis of alpha-Branched Carbonyl Compounds$248,499
R01 · FY2009 · GM · contact PI
Catalytic Synthesis of alpha-Branched Carbonyl Compounds$54,263
R01 · FY2009 · GM · contact PI
Catalytic Synthesis of alpha-Branched Carbonyl Compounds$248,499
R01 · FY2008 · GM · contact PI
Catalytic Synthesis of alpha-Branched Carbonyl Compounds$248,499
R01 · FY2007 · GM · contact PI
Catalytic Synthesis of alpha-Branched Carbonyl Compounds$255,921
R01 · FY2006 · GM · contact PI
Catalytic Synthesis of alpha-Branched Carbonyl Compounds$283,080
R01 · FY2005 · GM
Total Synthesis of Chloriolin B and Chloriolin C$27,927
F32 · FY2002 · GM
Total Synthesis of Chloriolin B and Chloriolin C$33,260
F32 · FY2001 · GM